PDGFA and neoplasm: High frequency of genetic alterations of tumor suppressors (e.g., PTEN and CDKN2A/CDKN2B) and oncogenes (e.g., PDGFA and EGFR) suggested that these cancer driver genes might be responsible for initiation of mGBM but not contribute to the progression of mGBM.